Skip to content

Released Nov 8, 2023, after the close

10-Q filed Nov 8, 2023, 39 days after period end · 0000950170-23-061134

Q3 2023 · 10-Q
Revenue$0.00no prior Q3 2022 on fileno prior Q2 2023 on file
Net Income-$14.42MN/M vs Q3 2022N/M vs Q2 2023
EPS Diluted-$3.29N/M vs Q3 2022N/M vs Q2 2023
Operating Income-$15,048,000N/M
Operating Cash Flowderived-$13,848,000N/M
Free Cash Flowderived-$13,984,000N/M

What the release said

The release

Same quarter

MetricQ3 2023Q3 2022Q3 2021Q3 2020
Revenue$0.00—$6.25M$34.61M
Net Income-$14.42M-$23.15M-$18.80M-$3.35M
EPS Diluted-$3.29-$0.48-$0.41-$0.09

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR